1.77 million Sinopharm vaccine doses under Covax scheme arrive in Dhaka

Another batch of 1.77 million doses of the Sinopharm Covid-19 vaccine has arrived in Dhaka through the Covax facility.

At 7:50 p.m. on Wednesday, the Biman flight carrying the vaccination doses arrived at Hazrat Shahjalal International Airport. The shipment departed Beijing on an Emirates Airlines flight at 7:20 a.m. local time on Wednesday, with a stopover in Doha.

Hualong Yan, the Chinese Embassy’s deputy chief of mission in Dhaka, confirmed the information in a Facebook post.

Bangladesh received 1.7 million vaccine doses from Sinopharm on Tuesday as part of the Covax facility. Dhaka’s embassy Bangladesh has gotten 11.57 million vaccination doses as a result of this.

Another batch of 1.77 million doses of the Sinopharm Covid-19 vaccine has arrived in Dhaka through the Covax facility.

At 7:50 p.m. on Wednesday, the Biman flight carrying the vaccination doses arrived at Hazrat Shahjalal International Airport.

The shipment departed Beijing on an Emirates Airlines flight at 7:20 a.m. local time on Wednesday, with a stopover in Doha.

Hualong Yan, the Chinese Embassy’s deputy chief of mission in Dhaka, confirmed the information in a Facebook post.

Bangladesh received 1.7 million vaccine doses from Sinopharm on Tuesday as part of the Covax facility. Bangladesh has now received a total of 11.57 million doses of the Sinopharm vaccine, thanks to the newest shipment.

The country had already received 7 million doses of the vaccine from China, which it had purchased. In addition, in July, China provided 1.1 million Sinopharm pills to Bangladesh in two consignments as a gift.

Bangladesh will get six million doses of the Pfizer-BioNTech vaccine in September, according to Foreign Minister AK Abdul Momen.

Aside from that, he stated that the country will soon receive one million doses of the Oxford-AstraZeneca vaccine, which will most likely be covered under the Covax program.

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments